Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing
Lifeward secured up to $11.2 million in strategic financing through a securities purchase agreement, closing approximately $5.6 million immediately with a matching amount committed upon achieving predefined commercial milestones. The additional capital tranche is tied to either a 150% increase in ReWalk unit sales or the stock price trading at or above $13.80 for ten consecutive days.
Key figures
- Initial closing usd
- 5600000
- Milestone price usd
- 13.8
- Additional commitment usd
- 5600000
- Oramed framework funded usd
- 10000000
- Oramed framework capacity usd
- 47000000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.